Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: ALK gene

FDA, Regulations

FDA clears Xalkori for inflammatory myofibroblastic tumours

July 15, 2022

Via: Pharmaphorum

Xalkori (crizotinib) has been cleared for inflammatory myofibroblastic tumours (IMT), which appear in organs like the lung, stomach, bladder or liver. While they are not cancerous and don’t tend to spread, local growth within the organs can cause problems. The […]